Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 15;7(3):238–248. doi: 10.14218/JCTH.2019.00008

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Authors.

This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2019.00008 and can also be viewed on the Journal’s website at http://www.jcthnet.com”.

PMC Copyright notice

Fig. 3. — Red indicates significant improvement compared with the control group; blue indicates no significant improvement. AST, TBIL, ALB and MELD were significantly improved (P < 0.05) in group HA. Only TBIL was significantly improved (P < 0.05) in group PV.

Abbreviations: ALB, albumin; AST, aspartate aminotransferase; F, fixed effects model; HA, hepatic artery; MELD, model for end-stage liver disease; Phet, p value of heterogeneity; PV, portal vein or peripheral vein; R, random effects models; TBiL, total bilirubin.